We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Towards the pharmacogenomics of cystic fibrosis

    Federica Sangiuolo

    Dipartimento di Biopatologia e Diagnostica per Immagini, Università di Roma Tor Vergata and Servizio di Genetica Medica Policlinico Universitario Tor Vergata, 00133 Roma, Italy

    ,
    Maria Rosaria D’Apice

    Dipartimento di Biopatologia e Diagnostica per Immagini, Università di Roma Tor Vergata and Servizio di Genetica Medica Policlinico Universitario Tor Vergata, 00133 Roma, Italy

    ,
    Emanuela Bruscia

    Dipartimento di Biopatologia e Diagnostica per Immagini, Università di Roma Tor Vergata and Servizio di Genetica Medica Policlinico Universitario Tor Vergata, 00133 Roma, Italy

    ,
    Vincenzina Lucidi

    Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy

    ,
    Giuseppe Novelli

    Dipartimento di Biopatologia e Diagnostica per Immagini, Università di Roma Tor Vergata and Servizio di Genetica Medica Policlinico Universitario Tor Vergata, 00133 Roma, Italy

    Published Online:https://doi.org/10.1517/14622416.3.1.75

    Keywords: cystic fibrosis, cystic fibrosis transmembrane conductance regulator, CFTR mutations, gene therapy, genotype-phenotype correlation, ion channel therapy, pharmacological treatment, protein-assisted therapy